Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02000024 · ClinicalTrials.gov registry record · NA

Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes

A NA study of Obesity and PreDiabetes, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT02000024: Completed NA study of Obesity and PreDiabetes, sponsored by Indiana University.

NCT02000024 is a NA study of Obesity and PreDiabetes that has completed, run by Indiana University. The registered enrollment target is 225 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02000024, a NA study of Obesity and PreDiabetes, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized pilot study to assess the applicability of the Weight Watchers model for lifestyle modification to the primary prevention of type 2 diabetes. The approach developed by Weight Watchers to achieve weight loss is based on similar nutritional principals and techniques used in the Diabetes Prevention Program (DPP) lifestyle intervention; monitoring food intake, exercising calorie control, setting modest weight loss goals and using physical activity.

Interventions

  • BEHAVIORAL Weight Watchers
  • BEHAVIORAL National Diabetes Education Program

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2011-12
Est. Completion 2016-03
Phase NA
Indiana University

890 total trials

What the finished NCT02000024 record still lists

NCT02000024 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (73% lower).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Weight Watchers is the first listed.

NCT02000024 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT02000024 about?

NCT02000024 is a clinical study titled "Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes". This study is a randomized pilot study to assess the applicability of the Weight Watchers model for lifestyle modification to the primary prevention of type 2 diabetes. The approach developed by Weight Watchers to achieve weight loss is based on similar nutritional principals and techniques used in ...

What is the current status of trial NCT02000024?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2011-12. Estimated completion is 2016-03.

What conditions does trial NCT02000024 study?

This clinical trial studies the following conditions: Obesity, PreDiabetes, Gestational Diabetes Mellitus.

What interventions are being tested in trial NCT02000024?

The interventions under investigation include: Weight Watchers (BEHAVIORAL), National Diabetes Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02000024?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02000024 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02000024's enrollment target sits among peer trials

225 287th of 1053 higher than 763 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02000024, the US trial registry maintained by the National Library of Medicine. NCT02000024 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.